64 related articles for article (PubMed ID: 23146463)
1. Treatment of Hypercalcemic Hyperparathyroidism After Kidney Transplantation Is Associated With Improved Allograft Survival.
Wang R; Reed RD; Price G; Abraham P; Lewis M; McMullin JL; MacLennan P; Killian C; Locke JE; Ong S; Kumar V; Gillis A; Lindeman B; Chen H; Fazendin J
Oncologist; 2024 Apr; 29(4):e467-e474. PubMed ID: 38006197
[TBL] [Abstract][Full Text] [Related]
2. Cinacalcet in hyperparathyroidism management after pediatric renal transplantation.
Niel O; Maisin A; Macher MA; Peuchmaur M; Deschênes G
CEN Case Rep; 2016 Nov; 5(2):141-143. PubMed ID: 28508965
[TBL] [Abstract][Full Text] [Related]
3. Surgery for Renal Hyperparathyroidism in the Era of Cinacalcet: A Single-Center Experience.
Mogl MT; Skachko T; Dobrindt EM; Reinke P; Bures C; Pratschke J; Rayes N
Scand J Surg; 2021 Mar; 110(1):66-72. PubMed ID: 31906794
[TBL] [Abstract][Full Text] [Related]
4. Cinacalcet for Symptomatic Hypercalcemia Caused by AP2S1 Mutations.
Howles SA; Hannan FM; Babinsky VN; Rogers A; Gorvin CM; Rust N; Richardson T; McKenna MJ; Nesbit MA; Thakker RV
N Engl J Med; 2016 Apr; 374(14):1396-1398. PubMed ID: 27050234
[No Abstract] [Full Text] [Related]
5. Hyperparathyroidism in chronic kidney disease: complexities within the commonplace.
Cai MM; McMahon LP; Smith ER; Williams DS; Holt SG
Clin Med (Lond); 2012 Aug; 12(4):333-7. PubMed ID: 22930877
[TBL] [Abstract][Full Text] [Related]
6. An infant developing hypercalcemia and hypophosphatemia due to the use of exclusively almond milk.
Salama M; Tebben PJ; Al Nofal A
J Pediatr Endocrinol Metab; 2024 Apr; 37(4):375-379. PubMed ID: 38414167
[TBL] [Abstract][Full Text] [Related]
7. Risk Factors for Posttransplant Erythrocytosis: Parathyroid Hormone Paradox?
Yeter HH; Fettahoglu F; Yesiloglu E; Akcay O; Korucu B; Bali M; Derici U
Exp Clin Transplant; 2024 Feb; 22(2):103-107. PubMed ID: 32370696
[TBL] [Abstract][Full Text] [Related]
8. Long-Term Use of Cinacalcet in Kidney Transplant Recipients With Hypercalcemic Secondary Hyperparathyroidism: A Single-Center Prospective Study.
Zavvos V; Fyssa L; Papasotiriou M; Papachristou E; Ntrinias T; Savvidaki E; Goumenos DS
Exp Clin Transplant; 2018 Jun; 16(3):287-293. PubMed ID: 29108515
[TBL] [Abstract][Full Text] [Related]
9. Systematic Review of the Treatment of Persistent Hyperparathyroidism Following Kidney Transplantation.
Miedziaszczyk M; Lacka K; Tomczak O; Bajon A; Primke M; Idasiak-Piechocka I
Biomedicines; 2022 Dec; 11(1):. PubMed ID: 36672533
[TBL] [Abstract][Full Text] [Related]
10. Mineral and Bone Disorders After Kidney Transplantation.
Vangala C; Pan J; Cotton RT; Ramanathan V
Front Med (Lausanne); 2018; 5():211. PubMed ID: 30109232
[TBL] [Abstract][Full Text] [Related]
11. Persistent and recurrent hyperparathyroidism.
Guerin C; Paladino NC; Lowery A; Castinetti F; Taieb D; Sebag F
Updates Surg; 2017 Jun; 69(2):161-169. PubMed ID: 28434176
[TBL] [Abstract][Full Text] [Related]
12. Secondary Hyperparthyroidism: Pathogenesis, Diagnosis, Preventive and Therapeutic Strategies.
Portillo MR; Rodríguez-Ortiz ME
Rev Endocr Metab Disord; 2017 Mar; 18(1):79-95. PubMed ID: 28378123
[TBL] [Abstract][Full Text] [Related]
13. Long-term clinical practice experience with cinacalcet for treatment of hypercalcemic hyperparathyroidism after kidney transplantation.
Thiem U; Gessl A; Borchhardt K
Biomed Res Int; 2015; 2015():292654. PubMed ID: 25861621
[TBL] [Abstract][Full Text] [Related]
14. Inverse association of serum vitamin D in relation to carotid intima-media thickness in Chinese postmenopausal women.
Hao Y; Ma X; Luo Y; Xu Y; Xiong Q; Zhu J; Bao Y; Jia W
PLoS One; 2015; 10(3):e0122803. PubMed ID: 25822845
[TBL] [Abstract][Full Text] [Related]
15. Associations of serum 25-hydroxyvitamin D3 levels with visceral adipose tissue in Chinese men with normal glucose tolerance.
Hao Y; Ma X; Shen Y; Ni J; Luo Y; Xiao Y; Bao Y; Jia W
PLoS One; 2014; 9(1):e86773. PubMed ID: 24466233
[TBL] [Abstract][Full Text] [Related]
16. Cinacalcet treatment for stable kidney transplantation patients with hypercalcemia due to persistent secondary hyperparathyroidism: a long-term follow-up.
Paschoalin RP; Torregrosa JV; Sánchez-Escuredo A; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Nov; 44(9):2588-9. PubMed ID: 23146463
[TBL] [Abstract][Full Text] [Related]
17. Cinacalcet de novo in persistent hypercalcemia after kidney transplantation secondary to hyperparathyroidism: long-term follow-up and effect of withdrawal.
Paschoalin RP; Torregrosa JV; Barros X; Durán CE; Campistol JM
Transplant Proc; 2012 Oct; 44(8):2376-8. PubMed ID: 23026597
[TBL] [Abstract][Full Text] [Related]
18. Evolution of secondary hyperparathyroidism after kidney transplantation in patients receiving cinacalcet on dialysis.
Torregrosa JV; Bergua C; Martinez de Osaba MJ; Oppenheimer F; Campistol JM
Transplant Proc; 2009; 41(6):2396-8. PubMed ID: 19715931
[TBL] [Abstract][Full Text] [Related]
19. Effect of cinacalcet on hypercalcemia and bone mineral density in renal transplanted patients with secondary hyperparathyroidism.
Bergua C; Torregrosa JV; Fuster D; Gutierrez-Dalmau A; Oppenheimer F; Campistol JM
Transplantation; 2008 Aug; 86(3):413-7. PubMed ID: 18698244
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
